Table 7.
Factors | 3-year OS | 3-year LRFS | 3-year DMFS | 3-year PFS |
---|---|---|---|---|
| ||||
Age (years) | ||||
<55 vs ≥55 | 0.572 | 0.483 | 0.396 | 0.424 |
Gender | ||||
Female vs male | 0.426 | 0.537 | 0.389 | 0.692 |
T stage | ||||
T1-2 vs T3-4 | 0.224 | 0.186 | 0.042* | 0.221 |
N stage | ||||
N0-1 vs N2-3 | 0.337 | 0.281 | 0.021* | 0.342 |
Use of CCRT | ||||
No vs yes | 0.398 | 0.592 | 0.424 | 0.482 |
GTVnx volume (cm3) | ||||
<40 vs ≥40 | 0.192 | 0.342 | 0.112 | 0.173 |
Note:
P<0.05.
Abbreviations: CCRT, concurrent chemoradiotherapy; DMFS, distant metastasis-free survival; LRFS, local relapse-free survival; OS, overall survival; PFS, progression-free survival.